HUP9900090A3 - Process and intermediates for preparing 1-(2-[2-isoxazol-3-ylbenzofuran-5-yloxy]ethylamino)-3-phenoxy-2(s)-ol - Google Patents

Process and intermediates for preparing 1-(2-[2-isoxazol-3-ylbenzofuran-5-yloxy]ethylamino)-3-phenoxy-2(s)-ol

Info

Publication number
HUP9900090A3
HUP9900090A3 HU9900090A HUP9900090A HUP9900090A3 HU P9900090 A3 HUP9900090 A3 HU P9900090A3 HU 9900090 A HU9900090 A HU 9900090A HU P9900090 A HUP9900090 A HU P9900090A HU P9900090 A3 HUP9900090 A3 HU P9900090A3
Authority
HU
Hungary
Prior art keywords
ylbenzofuran
isoxazol
yloxy
ethylamino
phenoxy
Prior art date
Application number
HU9900090A
Other languages
Hungarian (hu)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HUP9900090A2 publication Critical patent/HUP9900090A2/en
Publication of HUP9900090A3 publication Critical patent/HUP9900090A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HU9900090A 1995-10-31 1996-08-15 Process and intermediates for preparing 1-(2-[2-isoxazol-3-ylbenzofuran-5-yloxy]ethylamino)-3-phenoxy-2(s)-ol HUP9900090A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US815395P 1995-10-31 1995-10-31

Publications (2)

Publication Number Publication Date
HUP9900090A2 HUP9900090A2 (en) 1999-10-28
HUP9900090A3 true HUP9900090A3 (en) 1999-11-29

Family

ID=21730067

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900090A HUP9900090A3 (en) 1995-10-31 1996-08-15 Process and intermediates for preparing 1-(2-[2-isoxazol-3-ylbenzofuran-5-yloxy]ethylamino)-3-phenoxy-2(s)-ol

Country Status (15)

Country Link
EP (1) EP0861240A1 (en)
JP (1) JPH10513480A (en)
KR (1) KR19990067172A (en)
CN (1) CN1201455A (en)
AU (1) AU6628596A (en)
BR (1) BR9611217A (en)
CA (1) CA2234081A1 (en)
CZ (1) CZ130898A3 (en)
HR (1) HRP960502A2 (en)
HU (1) HUP9900090A3 (en)
IL (1) IL123623A0 (en)
PL (1) PL327997A1 (en)
TR (1) TR199800710T2 (en)
WO (1) WO1997016432A1 (en)
YU (1) YU57396A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120253481A1 (en) * 2011-03-29 2012-10-04 General Electric Company Hart channel interface component including redundancy
EP2653464B1 (en) 2012-04-20 2017-09-27 Rohm and Haas Company Benzylamine hydrophobe

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL312005A1 (en) * 1993-06-14 1996-04-01 Pfizer Binary amines as antidiabetic and antiobesitic agents

Also Published As

Publication number Publication date
CN1201455A (en) 1998-12-09
YU57396A (en) 1998-11-05
HUP9900090A2 (en) 1999-10-28
IL123623A0 (en) 1998-10-30
AU6628596A (en) 1997-05-22
MX9803497A (en) 1998-09-30
WO1997016432A1 (en) 1997-05-09
KR19990067172A (en) 1999-08-16
EP0861240A1 (en) 1998-09-02
HRP960502A2 (en) 1998-04-30
CA2234081A1 (en) 1997-05-09
CZ130898A3 (en) 1999-03-17
TR199800710T2 (en) 1998-08-21
BR9611217A (en) 1999-04-06
PL327997A1 (en) 1999-01-04
JPH10513480A (en) 1998-12-22

Similar Documents

Publication Publication Date Title
SG55098A1 (en) Naphthyl compounds intermediates compounds and methods
AU4237896A (en) Method and intermediates for the synthesis of korupensamines
AU1688295A (en) Method of personnel verification
PL314640A1 (en) Method of vaccinating against coccodiosis
IL115538A (en) Method and system for determination of the pressure-volume relationship of the heart
GB2289441B (en) Method of printing
HU9600320D0 (en) Process and new intermediates for the preparation of triazolinon-derivatives
PL320699A1 (en) Method of obtaining cephotaxime
IL118992A0 (en) Process and intermediates for preparing norbenzomorphan derivatives
HUP9900090A3 (en) Process and intermediates for preparing 1-(2-[2-isoxazol-3-ylbenzofuran-5-yloxy]ethylamino)-3-phenoxy-2(s)-ol
IL117849A0 (en) Process for the purification of glycoproteins
GB9502267D0 (en) Muffler for booster
AU1746595A (en) Method and system for the thermal analysis of a substance
SG44059A1 (en) Process for preparing acetoxyazetidinone derivative and intermediate thereof
AU2281395A (en) Method of hair analysis
PL306900A1 (en) Method of obtaining 1-amino-1-methylo-3(4)-cyano-cyclohexane
PL301929A1 (en) Method of obtaining epichlorohydine
AU3879095A (en) Process and intermediates for preparing triphenyltrifluoropropanes and -propenes
GB2309925B (en) Fixing method
HUP9601521A3 (en) Process for preparing substituted quinoline-intermediates and the intermediates arising from the process
GB9521925D0 (en) Method for replacing hair
GB9603309D0 (en) Method of authorisng transactions
PL303578A1 (en) Method of obtaining fertilisation supersorbents
GB9402469D0 (en) Language aid
ZA962914B (en) Process for the purification of glycoproteins